ChartMill · Jul 15, 2026
These stocks are moving in today's session
Let's have a look at what is happening on the US markets in the middle of the day on Wednesday. Below you can find the top gainers and losers in today's session.
AP
NASDAQ · APLMW
Apollomics, Inc.
Financial Services · Financial - Conglomerates
$0.01
Up+$0.00 (+6.25%)
Updated Oct 31, 2026, 2:14 PM
SID Score
4.3/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 175.88M
- P/E ratio
- -0.71
- Dividend yield
- 0.00%
- 52-week range
- $0.01 – $0.23
- Volume
- 11.26K
- Avg. volume
- 89.53K
Price performance · APLMW
APLMW price history
1M range · 14 trading sessions · Daily adjusted prices
Prices through Oct 30, 2026
APLMW closed at $0.01 after 14 trading sessions, up 13.33% for the selected period.
- Last close
- $0.01
- Period change
- +13.33%
- Period low
- $0.01
- Period high
- $0.01
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 30, 2026 | $0.0112 | $0.0124 | $0.0112 | $0.0119 | 11.26K |
| Oct 29, 2026 | $0.0112 | $0.0112 | $0.0112 | $0.0112 | 2.85K |
| Oct 28, 2026 | $0.0103 | $0.0103 | $0.0102 | $0.0102 | 3.85K |
| Oct 26, 2026 | $0.0103 | $0.0104 | $0.0103 | $0.0104 | 2.38K |
| Oct 23, 2026 | $0.0101 | $0.0114 | $0.0101 | $0.0112 | 81.12K |
| Oct 22, 2026 | $0.0109 | $0.0109 | $0.0109 | $0.0109 | 114 |
| Oct 19, 2026 | $0.0109 | $0.0109 | $0.0109 | $0.0109 | 6.05K |
| Oct 16, 2026 | $0.0118 | $0.0118 | $0.0101 | $0.0101 | 3.95K |
| Oct 15, 2026 | $0.011 | $0.0111 | $0.01 | $0.0103 | 42.55K |
| Oct 14, 2026 | $0.0102 | $0.0102 | $0.0101 | $0.0101 | 10.69K |
| Oct 7, 2026 | $0.0101 | $0.0101 | $0.0101 | $0.0101 | 1.52K |
| Oct 6, 2026 | $0.0105 | $0.0105 | $0.0105 | $0.0105 | 503 |
| Oct 5, 2026 | $0.0129 | $0.0129 | $0.0104 | $0.0104 | 50.64K |
| Oct 2, 2026 | $0.0131 | $0.0131 | $0.0101 | $0.0105 | 907 |
Latest APLMW news
The latest Smart Investors Daily articles mentioning APLMW.
Stock researchCompany · Overview
Company
Market Activity
Research & News
APLMW research
Overview
Company profile and research snapshot.
Company profile
Apollomics Inc is an clinical-stage biopharmaceutical company focused on the discovery and development of oncology therapies with the potential to be combined with other treatment options to harness the immune system and target specific molecular pathways to inhibit cancer. The company programs include vebreltinib (APL-101), a potent, selective c-Met inhibitor for the treatment of non-small cell lung cancer and other tumors with c-Met alterations, and uproleselan (APL-106), a specific E-Selectin antagonist that has the potential to be used adjunctively with standard chemotherapy to treat acute myeloid leukemia.
Visit company websiteAnalyst outlook
Consensus and target data currently published for this company.
- Consensus
- —
- Average target
- —
- Implied upside
- —
- Analysts
- —
News briefing
No generated briefing is available yet.
ChartMill · Jul 9, 2026
Let's take a look at the stocks that are in motion in today's session.
Wondering how the US markets performed in the middle of the day on Thursday? Discover the movers and shakers of today's session in our comprehensive analysis.
ChartMill · Jul 9, 2026
There are notable gap-ups and gap-downs in today's session.
Investors and traders are closely monitoring the gap up and gap down stocks in today's session on Thursday. Let's explore the market movements and identify the stocks with significant gaps.
ChartMill · Jul 8, 2026
Top movers in Wednesday's pre-market session
Discover the top movers in Wednesday's pre-market session and stay informed about market dynamics.
AI research layers
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
